ILA Price sensitive 29 Sep 2025, 8:29 AM

US FDA Type C meeting briefing document submitted

Island Pharmaceuticals Ltd

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in